ALDN, from a technology perspective continually receives awards in data security - and technically from a chart perspective it looks like it wants to run

Alternative Energy Play - great sector now and spin off of Cobasys division should give it a nice pop

Biomedical with very hot cancer vaccine (TroVax potential wide range of tumours, including renal, colorectal, lung, breast and prostrate cancer. It is currently in late stage trials as a treatment for kidney cancer and this is expected to go to market by 2009. Sanofi is to develop the vaccine to treat colorectal cancer.... And partnered with "A" list partners: Sanofi-Aventis and the targeted antibody therapy collaboration with Wyeth, Arius Research, Intervet, MolMed, Sigma-Aldrich, Viragen, Virxsys and Wyeth. and licence agreements with Biogen Idec, GlaxoSmithKline, Merck & Co, Pfizer.

Making great profits and showing accelerated growth w/o MRAM and has moved beyond the MRAM story into a viable, profitable company with accelerated revenue growth. If MRAM ever comes about it will be the frosting on the cake.

great pipeline and partnerships - recommended by Motley Fool "rule breakers"

my favorite Canadian Oil Trust -

Love offshore drillers

"April 25, 2007 announcement of statistically significant results with BEMA(TM) Fentanyl in treating cancer patients with breakthrough pain in the company's Phase III efficacy clinical trial. BDSI plans to include today's study results, the efficacy trial results and other materials in its planned New Drug Application (NDA) to the FDA for BEMA(TM) Fentanyl. The NDA submission is expected during the third quarter of 2007." Holding for 1-2 years BDSI will really take off - $45-$65 range given $250M conservative sales projections * 2-4 price to sales ratio / shares outstanding